The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working GroupKhalid El Bairi, John M.S. Bartlett, Farid Azmoudeh Ardalan et al.|npj Breast Cancer|2021Cited by 282
A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patientsAlberto Zori Comba, A. Schmilovich, C. Blajman et al.|European Journal of Cancer|2001Cited by 37
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancerJosé Rodrigues Pereira, Maximiliano Van Kooten, Luis Fein et al.|Lung Cancer|2007Cited by 11
Uracil/tegafur plus oral calcium folinate in advanced breast cancer.Eduardo Richardet, Luis Fein, C.M. Pedraza et al.|PubMed|1999Cited by 6
Paclitaxel (P) plus carboplatin (C) in advanced non-small cell lung cancer (NSCLC)Eduardo Richardet, Lydia Suarez, Federico Cóppola et al.|Lung Cancer|2000Cited by 0